MEGAROBO
PrivateLast Round
Series D
6/24/2025
Est. Valuation
$1.4B
Total Funding Raised
$418.8M
Momentum Score
25 /100
Company Overview
MEGAROBO is a technology company that provides artificial intelligence and robotics solutions. Founded in 2016 and headquartered in Beijing, China, the company focuses on developing automation solutions for various industries, with a significant emphasis on life sciences, as well as industrial automation and smart retail. MEGAROBO's products range from benchtop workflow automation to fully integrated platforms for complex laboratory processes, aiming to improve efficiency and address labor shortages. The company has raised substantial venture capital, including a $300 million Series C round in 2022, to fund research and development, increase production capacity, and support global expansion.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Industrial Robotics, Drug Discovery, Smart Manufacturing, Workflow Automation
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MEGAROBO Comps
Public and private peers based on sector, stage, and business model.
MEGAROBO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 6/24/2025 | ||||
| Series C | 6/15/2022 | ||||
| Series B Extension | 5/28/2021 | ||||
| Series B | 11/2/2020 | ||||
| Series A Extension | 7/16/2019 | ||||
Series A | 6/4/2018 |
MEGAROBO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redview Capital | Series C |
| Gobi Partners | Series A Extension |
| Joy Capital | Series A Extension, Series B, Series B Extension, Series A |
| Granite Asia | Series D |
| MOOC-CN Investment | Series C |
| Suzhou Guofa Venture Capital | Series D |
| Pavilion Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
Integrates AI operating system with antibody discovery platforms.
MEGAROBO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MEGAROBO's valuation, stock price, and market status.
